Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 3/20 | 0.39 |
| ▸ | CA2 | P00918 | 3/20 | 0.39 |
| ▸ | CA4 | P22748 | 3/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | MIF | P14174 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | ESR1 | P03372 | 2/20 | 0.35 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.35 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.35 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.35 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.35 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.35 |
| ▸ | TNKS | O95271 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2480692 | 0.87 | KDM4E (0.49) | KDM4EMAPK1CA1CA2CA4 | |
| SCHEMBL490186 | 0.80 | KDM4E (0.49) | KDM4EMAPK1CA1CA2CA4 | |
| SCHEMBL1072586 | 0.80 | KDM4E (0.55) | KDM4EMAPK1CA1CA2CA4 | |
| SCHEMBL1173259 | 0.79 | KDM4E (0.66) | KDM4EMAPK1CA1CA2CA4 | |
| SCHEMBL5271345 | 0.77 | KDM4E (0.46) | KDM4EMAPK1CA1CA2CA4 | |
| SCHEMBL18797918 | 0.74 | CA1 (0.52) | KDM4EMAPK1CA1CA2CA4 | |
| SCHEMBL5179255 | 0.73 | KDM4E (0.76) | KDM4EMAPK1CA1CA2CA4 | |
| SCHEMBL819054 | 0.73 | CA1 (0.56) | KDM4EMAPK1CA1CA2CA4 | |
| SCHEMBL28414685 | 0.73 | CA1 (0.56) | KDM4EMAPK1CA1CA2CA4 | |
| SCHEMBL8218747 | 0.72 | KDM4E (0.66) | KDM4EMAPK1CA1CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 220 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100047185-A1 | ACTVIE SUBSTANCE COMBINATION | ISDIN S.A. (ES) | 2010-02-25 | — | — | US | claimed |
| WO-2008083975-A1 | LIGHT-STABILIZED COMPOSITION | ISDIN S.A. (ES) | 2008-07-17 | — | — | WO | claimed |
| WO-2008083974-A1 | ACTIVE SUBSTANCE COMBINATION | ISDIN S.A. (ES) | 2008-07-17 | — | — | WO | claimed |
| WO-2008067928-A1 | UV ABSORBING COMPOSITIONS CONTAINING A PYRROLYLTRIAZINE | ISDIN S.A. (ES) | 2008-06-12 | — | — | WO | claimed |
| US-20260078211-A1 | A SOLID PARTICLE OF ORGANOSILICON-FUNCTIONAL CO-POLYMER, MANUFACTURING PROCESS THEREOF, AND COSMETICS COMPRISING SAID SOLID PARTICLE | DOW TORAY CO LTD (JP) | 2026-03-19 | — | — | US | disclosed |
| US-20260076892-A1 | GEL COMPOSITION AND OIL-IN-WATER COMPOSITION | SHISEIDO COMPANY, LTD. (JP) | 2026-03-19 | — | — | US | disclosed |
| EP-4628568-A1 | GEL CLEANING AGENT AND METHOD FOR PRODUCING THE SAME | Shiseido Honeycake Industries Co., Ltd. (JP) | 2025-10-08 | — | — | EP | disclosed |
| US-20250283012-A1 | GEL CLEANING AGENT AND METHOD FOR PRODUCING THE SAME | SHISEIDO HONEYCAKE INDUSTRIES CO., LTD. (JP) | 2025-09-11 | — | — | US | disclosed |
| EP-4599819-A1 | GEL COMPOSITION AND OIL-IN-WATER-TYPE COMPOSITION | Shiseido Company, Ltd. (JP) | 2025-08-13 | — | — | EP | disclosed |
| US-20250195384-A1 | COSMETIC | SHISEIDO COMPANY, LTD. (JP) | 2025-06-19 | — | — | US | disclosed |
| EP-4516284-A1 | COSMETIC | Shiseido Company, Ltd. (JP) | 2025-03-05 | — | — | EP | disclosed |
| US-12138329-B2 | Gel cleansing agent | SHISEIDO HONEYCAKE INDUSTRIES CO., LTD. (JP) | 2024-11-12 | — | — | US | disclosed |
| WO-2003066015-A1 | COMPOSITION FOR SKIN WHITENING CONTAINING LYSOPHOSPHATIDYLETHANOLAMINE AS AN ACTIVE INGREDIENT | DOOSAN CORPORATION (KR) | 2003-08-14 | — | — | WO | disclosed |
| US-20030091603-A1 | Skin preparations for external use | SHISEIDO COMPANY, LTD. (JP) | 2003-05-15 | — | — | US | disclosed |
| EP-1165039-A2 | DERMATOLOGICAL TOPICAL COMPOSITION | Pentapharm A.G. (CH) | 2002-01-02 | — | — | EP | disclosed |
| EP-1153602-A1 | SKIN PREPARATIONS FOR EXTERNAL USE | SHISEIDO COMPANY LIMITED (JP) | 2001-11-14 | — | — | EP | disclosed |
| US-6150425-A | COMPRISING AN OUTER PHASE OIL AND OIL IN WATER EMULSION IN THE INNER PHASE WHICH CONTAINING WATER, AN OIL BASED INGREDIENT, A SURFACTANT AND AN AMPHIPHILIC SUBSTANCE; PREPARED BY A HIGH PRESSURE OR ULTRASONIC EMULSIFICATION | SHISEIDO COMPANY, LTD. (JP) | 2000-11-21 | — | — | US | disclosed |
| WO-2000057840-A2 | DERMATOLOGICAL TOPICAL COMPOSITION | PENTAPHARM AG (CH) | 2000-10-05 | — | — | WO | disclosed |
| EP-1002515-A1 | SKIN COMPOSITIONS FOR EXTERNAL USE | SHISEIDO COMPANY LIMITED (JP) | 2000-05-24 | — | — | EP | disclosed |
| EP-0970741-A1 | O/W/O TYPE MULTIPHASE EMULSION | SHISEIDO COMPANY LIMITED (JP) | 2000-01-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260076892-A1 | GEL COMPOSITION AND OIL-IN-WATER COMPOSITION | SGMS1, SGMS2, CETP | KDM4E 3677/4885MAPK1 2111/4885CA1 2478/4885 |
| US-20260078211-A1 | A SOLID PARTICLE OF ORGANOSILICON-FUNCTIONAL CO-POLYMER, MANUFACTURING PROCESS THEREOF, AND COSMETICS COMPRISING SAID SOLID PARTICLE | FOXM1, FOXK1, TAF1L | KDM4E 3029/4885MAPK1 2554/4885CA1 991/4885 |
| US-20030091603-A1 | Skin preparations for external use | CUTA, POLR1C, ACMSD | KDM4E 592/4885MAPK1 3899/4885CA1 2923/4885 |
| US-12138329-B2 | Gel cleansing agent | MPG, PARG, CHIA | KDM4E 690/4885MAPK1 3427/4885CA1 2818/4885 |
| US-20100047185-A1 | ACTVIE SUBSTANCE COMBINATION | UGT2B17, TACR2, UGT1A1 | KDM4E 3725/4885MAPK1 4141/4885CA1 2294/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.